SMTL ID : 7shu.2 (1 other biounit)

IgE-Fc in complex with omalizumab variant C02

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.75 Å

Oligo State

hetero-1-1-2-mer

Ligands

1 x NAG- BMA- MAN: beta-D-mannopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-BMA-MAN.1: 4 residues within 4Å: Chain A: N.29, T.31, G.75, S.76 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.29, A:T.31, A:G.75

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Pennington, L.F. et al., Directed evolution of and structural insights into antibody-mediated disruption of a stable receptor-ligand complex. Nat Commun (2021)

Release Date

2021-12-15

Peptides

omalizumab variant C02 VH: A
omalizumab variant C02 VL: B
Immunoglobulin heavy constant epsilon: CD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

C
A

D
A

omalizumab variant C02 VH

omalizumab variant C02 VL

Immunoglobulin heavy constant epsilon

Related Entries With Identical Sequence